The milan clinical trial with cyclosporine in cadaveric renal transplantation

A three-year follow-up

Claudio Ponticelli, Luigi Minetti, Filippo Quarto Di Palo, Antonio Vegeto, Lino Belli, Giuseppe Corbetta, Antonino Tarantino, Giovanni Civati

Research output: Contribution to journalArticle

60 Citations (Scopus)

Abstract

Between February and November 1983, 108 recipients of cadaveric renal transplants entered a randomized multicenter trial and were treated either with cyclosporine (CsA) and prednisone (n=55) or with conventional treatment based on azathioprine (Aza) and glucocorticoids (n=53). The graft survival probability at 3 years was 76% for CsA patients and 48% for Aza patients (P

Original languageEnglish
Pages (from-to)908-913
Number of pages6
JournalTransplantation
Volume45
Issue number5
Publication statusPublished - 1988

Fingerprint

Azathioprine
Kidney Transplantation
Cyclosporine
Clinical Trials
Graft Survival
Prednisone
Glucocorticoids
Multicenter Studies
Transplants
Kidney
Therapeutics

ASJC Scopus subject areas

  • Transplantation
  • Immunology

Cite this

Ponticelli, C., Minetti, L., Quarto Di Palo, F., Vegeto, A., Belli, L., Corbetta, G., ... Civati, G. (1988). The milan clinical trial with cyclosporine in cadaveric renal transplantation: A three-year follow-up. Transplantation, 45(5), 908-913.

The milan clinical trial with cyclosporine in cadaveric renal transplantation : A three-year follow-up. / Ponticelli, Claudio; Minetti, Luigi; Quarto Di Palo, Filippo; Vegeto, Antonio; Belli, Lino; Corbetta, Giuseppe; Tarantino, Antonino; Civati, Giovanni.

In: Transplantation, Vol. 45, No. 5, 1988, p. 908-913.

Research output: Contribution to journalArticle

Ponticelli, C, Minetti, L, Quarto Di Palo, F, Vegeto, A, Belli, L, Corbetta, G, Tarantino, A & Civati, G 1988, 'The milan clinical trial with cyclosporine in cadaveric renal transplantation: A three-year follow-up', Transplantation, vol. 45, no. 5, pp. 908-913.
Ponticelli C, Minetti L, Quarto Di Palo F, Vegeto A, Belli L, Corbetta G et al. The milan clinical trial with cyclosporine in cadaveric renal transplantation: A three-year follow-up. Transplantation. 1988;45(5):908-913.
Ponticelli, Claudio ; Minetti, Luigi ; Quarto Di Palo, Filippo ; Vegeto, Antonio ; Belli, Lino ; Corbetta, Giuseppe ; Tarantino, Antonino ; Civati, Giovanni. / The milan clinical trial with cyclosporine in cadaveric renal transplantation : A three-year follow-up. In: Transplantation. 1988 ; Vol. 45, No. 5. pp. 908-913.
@article{b3c435160e58465b8db73b388e0061b6,
title = "The milan clinical trial with cyclosporine in cadaveric renal transplantation: A three-year follow-up",
abstract = "Between February and November 1983, 108 recipients of cadaveric renal transplants entered a randomized multicenter trial and were treated either with cyclosporine (CsA) and prednisone (n=55) or with conventional treatment based on azathioprine (Aza) and glucocorticoids (n=53). The graft survival probability at 3 years was 76{\%} for CsA patients and 48{\%} for Aza patients (P",
author = "Claudio Ponticelli and Luigi Minetti and {Quarto Di Palo}, Filippo and Antonio Vegeto and Lino Belli and Giuseppe Corbetta and Antonino Tarantino and Giovanni Civati",
year = "1988",
language = "English",
volume = "45",
pages = "908--913",
journal = "Transplantation",
issn = "0041-1337",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - The milan clinical trial with cyclosporine in cadaveric renal transplantation

T2 - A three-year follow-up

AU - Ponticelli, Claudio

AU - Minetti, Luigi

AU - Quarto Di Palo, Filippo

AU - Vegeto, Antonio

AU - Belli, Lino

AU - Corbetta, Giuseppe

AU - Tarantino, Antonino

AU - Civati, Giovanni

PY - 1988

Y1 - 1988

N2 - Between February and November 1983, 108 recipients of cadaveric renal transplants entered a randomized multicenter trial and were treated either with cyclosporine (CsA) and prednisone (n=55) or with conventional treatment based on azathioprine (Aza) and glucocorticoids (n=53). The graft survival probability at 3 years was 76% for CsA patients and 48% for Aza patients (P

AB - Between February and November 1983, 108 recipients of cadaveric renal transplants entered a randomized multicenter trial and were treated either with cyclosporine (CsA) and prednisone (n=55) or with conventional treatment based on azathioprine (Aza) and glucocorticoids (n=53). The graft survival probability at 3 years was 76% for CsA patients and 48% for Aza patients (P

UR - http://www.scopus.com/inward/record.url?scp=0023785176&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023785176&partnerID=8YFLogxK

M3 - Article

VL - 45

SP - 908

EP - 913

JO - Transplantation

JF - Transplantation

SN - 0041-1337

IS - 5

ER -